Japan's CML treatment patterns revealed in large database study
NCT ID NCT07150793
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times
Summary
This study examined medical records of 754 people with chronic myeloid leukemia (CML) in Japan to see which medications (called TKIs) they received, how often they switched or stopped treatment, and what healthcare costs were involved. The goal was to understand real-world treatment patterns, not to test a new drug. No direct benefit to participants was expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOID LEUKEMIA, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.